Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update.

about

Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update.

Item

http://www.wikidata.org/entity/Q47133403

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Medulloblastoma in children an ...... cal trials and biology update.

@en

Medulloblastoma in children an ...... cal trials and biology update.

@nl

type

Item

label

Medulloblastoma in children an ...... cal trials and biology update.

@en

Medulloblastoma in children an ...... cal trials and biology update.

@nl

prefLabel

Medulloblastoma in children an ...... cal trials and biology update.

@en

Medulloblastoma in children an ...... cal trials and biology update.

@nl

P1476

Medulloblastoma in children an ...... ical trials and biology update

@en

P2093

Alvaro Lassaletta

http://www.w3.org/2001/XMLSchema#string

Fernando Carceller

http://www.w3.org/2001/XMLSchema#string

Lucas Moreno

http://www.w3.org/2001/XMLSchema#string

Luis Madero

http://www.w3.org/2001/XMLSchema#string

Victoria Fioravantti

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Pediatric medulloblastoma - update on molecular classification driving targeted therapies

Molecular subgroups of medulloblastoma: the current consensus

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

Phase I study of oral cyclophosphamide and oral topotecan for children with recurrent or refractory solid tumors.

Phase I study of fotemustine in pediatric patients with refractory brain tumors.

Phase I clinical and pharmacologic study of weekly cisplatin and irinotecan combined with amifostine for refractory solid tumors.

Dose finding and O6-alkylguanine-DNA alkyltransferase study of cisplatin combined with temozolomide in paediatric solid malignancies.

Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group study.

Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours.

P304

2606-2624

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.1171

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Teresa de Rojas

Francisco Bautista

P5008

ScienceSource

P577

2017-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28980418

http://www.w3.org/2001/XMLSchema#string

P921

medulloblastoma

phase I clinical trial

targeted therapy

antineoplastic combined chemotherapy protocols

cerebellar neoplasm

P932

5673921

http://www.w3.org/2001/XMLSchema#string